[Ethyl-Toxic Steatohepatitis, the "Quiet Killer" - from Inflamed Fat to Multi-Organ Failure].
[Ethyl-Toxic Steatohepatitis, the "Quiet Killer" - from Inflamed Fat to Multi-Organ Failure].
Praxis (Bern 1994). 2020 Jul;109(9):677-686
Authors: Kucsora N, Becker B
Abstract
Ethyl-Toxic Steatohepatitis, the "Quiet Killer" - from Inflamed Fat to Multi-Organ Failure Abstract. The spectrum of the alcohol-associated liver disease (ALD) includes the potentially reversible simple fatty degeneration of the liver (AFLD), ethyl-toxic steatohepatitis (ASH), and the ethyl-toxic liver cirrhosis. Despite an interdisciplinary andn intensive care approach, alcohol-associated steatohepatitis (ASH), clinically characterized by jaundice and SIRS, may, in case of a fulminant course and due to the limited therapeutic options, have a mortality rate of up to 40 % . In highly selected cases, if the basic medical care of corticosteroids combined with N-acetylcysteine fails, a liver transplantation might be discussed, which occasionally shows a satisfactory long-term course. With the presented case we would like to raise awareness about the underlying disease, emphasize prevention, and summarize the most important facts for the clinical practice.
PMID: 32635847 [PubMed - in process]
Source: Praxis - Category: General Medicine Authors: Kucsora N, Becker B Tags: Praxis (Bern 1994) Source Type: research
More News: Acetylcysteine | Alcoholism | Cirrhosis | Corticosteroid Therapy | General Medicine | Intensive Care | Jaundice | Liver | Liver Disease | Liver Transplant | Toxicology | Transplants | Urology & Nephrology